Market-View-Feature-Image

View on market: Stay Cautious, be with quality business:

Asian stocks opened mostly lower Tuesday after the S&P 500 closed lower for the fifth consecutive session. Japan shares declined and Australian equities also fell while South Korea advanced. U.S. contracts were volatile after the S&P 500 posted its longest losing streak in over three months. The Nasdaq 100 recovered to end with gains after sliding as much as 2.7%.The Singapore-traded SGX Nifty, an early indicator of India’s Nifty 50 Index’s performance, shed 0.25% to 18002.50, as of 8:25 a.m Elsewhere, Bitcoin recovered to around $42,000 after dipping below $40,000, putting it on track for its worst start to a year since the earliest days of digital currencies. Oil edged up.

Economic Calendar:

  • INR: CPI December on 12th January, 2022.
  • INR: IIP Data of Dec on 12th January 2022.
  • USD: FOMC Member George Speaks on 11th January, 2022.
  • USD: Core CPI on 12th January, 2022.

Earnings: Deltacorp, Hathway Datacom Ltd

Results:

GNA Axles: The Company’s standalone profit fall nearly 37 percent YoY to Rs 16.67 crore, while revenue came in 9 percent lower at Rs 301.6 crore in Q3FY22.

5paisa Capital : The company reported consolidated profit at Rs 0.74 crore in Q3FY22 against Rs 3.18 crore in Q3FY21 while its revenue jumped to Rs 80.05 crore from Rs 49.56 crore YoY.

Brokerage Radar:

JEFFERIES ON COFROGE: Initiate Buy, Target Price Rs 7400 Has undergone a transformation over past 3 yrs Over FY22-24, expect Co to deliver 18% cc revenue growth- much higher than 10-12% growth in large-cap IT firms & at upper-end of mid-cap IT firms. Its recent re-rating reflects its turnaround & is justified in context of its growth, evident from 1.6x PEG ratio With top line of $0.9bn & growth levers, well-placed to deliver 15-20% top-line growth over next 5 yrs.

MORGAN STANLEY ON PB FINTECH: Equalweight, Target Price RS 1160 Insurance premiums & loan disbursements for 3QF22 much stronger; for 9MF22 broadly in line See upside risk to our 3Q rev forecasts This makes 40% or higher revenue growth for F22 more visible, which investors should view Positively.

MORGAN STANLEY ON PAYTM: Overweight, Target Price Rs 1850 Dec-21 another strong mth across key metrics GMV rose 112% YoY in Dec-21 MTU was up 37% YoY to 64.4mn in F3Q22 Total devices deployed increased to 2m vs. 1.6m last mth Loans disbursed were Rs8.6bn (vs. Rs6.3bn-Rs6.9bn in Oct-Nov21).

JEFFERIES ON STEEL: Downgrade TATA Steel from Buy to Hold, TP Rs 1240 (7% upside) Downgrade JSW Steel from Buy to U-P, TP Rs 600 (11% downside) Like Novelis’ downstream biz, retain buy on Hindalco, TP Rs 660 (34% upside) Cut FY23 EPS for TATA/JSW by 18%/26%.

JP MORGAN ON L&T: Overweight, Target Price Rs 2300 3Q22E: Order Inflow trend lends hope to guidance maintenance Estimate 12.8% / 14.1% YoY core / consol revenue growth and 9.7% core margin driving overall net profit growth of 10% to Rs24.9bn. See medium term catalysts underpinned by govt capex & int order pick up, meanwhile private capex has room to grow from trough levels Co’s solid FCFE with asset monetization

International Markets:

U.S & Europe

Particulars 10th Jan Chg Chg(%)
Nasdaq 14,942.83 6.93 0.05
Dow 36068.87 -162.79 -0.45
FTSE 7,445.25 -40.03 -0.53
CAC 7,115.77 -103.71 -1.44
DAX 15,768.27 -179.47 -1.13
Dow Fut.* 36112.5 43.6 0.12

Asian markets:

Particulars 11th Jan Chg. Chg(%)
SGX Nifty 18,002.00 -45.5 -0.25
Nikkei 28,231.31 -247.25 -0.87
Straits Times 3,232.94 5.89 0.18
Hang Seng 23,763.11 16.57 0.07
Shanghai 3,595.32 1.8 0.05

ADR Watch:

Particulars 10th Jan Chg. Chg.(%)
Dr Reddy 63.65 -0.29 -0.45
HDFC Bank 68.1 0.86 1.28
ICICI Bank 21.15 0.27 1.29
Infosys 24.11 -0.19 -0.78
Tata Motor 32.85 0.9 2.82
Wipro 9.55 0.04 0.42

Commodities & Currency:

Particulars Current Price Chg(%)
USD/INR 74.04 -0.36
Brent 81.34 0.39
Gold 1805.25 0.36
Silver 22.562 0.45

FIIs & DII

Particulars 10th Jan 7th Jan
FIIs -124.23 496.27
DIIs 481.55 -115.66

News Update:

Axis Bank : Axis Bank said it has executed transaction for Arcelor Mittal Nippon Steel India and Lalit Pipes & Pipes on Secured Logistics Document Exchange. In another development, Rajiv Anand has been re-appointed as the deputy MD for 3 years from August 4, 2022.

Unichem Laboratories : Porinju Veliyath-owned Equity Intelligence India acquired 54,850 equity shares of Unichem Laboratories through open market transactions, thereby increasing its shareholding to 5.01 percent from 4.93 percent.

Fortis Healthcare : The US-based trust Emqore Envesecure has filed a suit against the company, promoter and others for copyright infringement. It has claimed $6.5 billion damage in the suit.

Indo Count Industries : ICRA has upgraded its credit rating for the company’s long term bank facilities and reaffirmed credit rating for the short term bank facilities.

One 97 Communications (Paytm) : Number of loans disbursed through its platform increased by 401 percent YoY to 0.44 crore loans in Q3FY 2022. In Q3 FY 2022, the value of loans disbursed through the platform was Rs 2,180 crore, an increase of 365 percent YoY. The company has seen stellar growth in each of its lending products

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL